Market News & Trends
Mustang Bio Licenses LentiBOOST Technology From SIRION Biotech
Mustang Bio, Inc. and SIRION Biotech GmbH recently announced a licensing agreement under which Mustang has acquired rights to SIRION’s LentiBOOST technology for the development…
Gerresheimer Includes Stevanato Group Integrated Twist-Off Closure System Solution for Gx RTF Syringes
Gerresheimer will offer its Gx RTF syringes with SG ITC (Integrated Tip Cap) twist-off closure of the Stevanato Group. With this technology, which is often…
Gelest Shareholders Close Sale to Mitsubishi Chemical
Gelest recently announced it has completed the sale of Gelest Intermediate Holdings to Mitsubishi Chemical America, Inc., the US subsidiary of Mitsubishi Chemical Corporation. Gelest…
Evaxion Biotech Launches New AI Powered Platform to Enable Faster Response to Emerging Viral Pandemics
Evaxion Biotech recently announced it has received approximately $800,000 in funding from Innovation Fund Denmark for the development of its new RAVEN platform, an integral…
Catalent Launches OneXpress Solution to Accelerate Oral Dosage Products From Clinic to Launch
Catalent recently announced the launch of its new OneXpress service for the integrated development, scale up, and manufacturing of new oral solid dosage forms. The…
AiViva Biopharma Initiates Phase 1/2 Clinical Trial of AIV001 for Nonmelanoma Skin Cancer
AiViva Biopharma Inc. recently announced it has begun dosing patients diagnosed with superficial or nodular basal cell carcinoma (BCC) with AIV001. AIV001 is AiViva’s novel…
Proveris Scientific Research Collaboration: New Generation Technologies for Improved Measurement of Pharmaceutical Aerosols
Proveris Scientific Corporation recently announced its research collaboration with The University of Sydney and Macquarie University on a project to develop a new generation of technologies for improving….
Recipharm Signs Agreement With Arcturus Therapeutics to Support the Manufacture of LUNAR-COV19 (ARCT-021) Vaccine Candidate
Recipharm has recently entered into an agreement with Arcturus Therapeutics, a leading US-based clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and….
First Commercial Drug Manufactured Via Ajinomoto Bio-Pharma Services’ AJIPHASE Technology Receives FDA Approval
Ajinomoto Bio-Pharma Services recently announce the US FDA has approved the first commercial drug manufactured via Aji Bio-Pharma’s proprietary AJIPHASE production process…..
Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion
Bristol Myers Squibb and MyoKardia, Inc. recently announced a definitive merger agreement under which Bristol Myers Squibb will acquire MyoKardia for $13.1 billion, or….
Evonik Launches New Oral Drug Delivery Technology for Enteric Protection & Rapid Release in the Upper Small Intestine
Evonik has recently launched an advanced oral drug delivery technology that provides enteric protection followed by rapid, homogeneous release for effective….
Schott AG & Credence MedSystems Form Strategic Collaboration Agreement
Credence MedSystems and SCHOTT AG have recently formed a collaboration for the application of Credence Companion technology with SCHOTT’s prefillable syriQ glass and SCHOTT TOPPAC polymer syringe systems…..
Mott's Controlled Release Drug Diffusion Studies Reduce In Vitro Test Time by Over 90% & Narrow Scope of Animal Trials
Device diffusion testing is a critical step that can delay the time for an implantable drug delivery device to get through clinical trials, regulatory hurdles and ultimately, to market. Mott conducts controlled release studies for….
Veru Completes Enrollment of Phase 2 Clinical Trial of Novel Oral Drug
Veru Inc. recently announced it has fully enrolled its Phase 2 clinical study of VERU-111, its novel, oral, alpha and beta tubulin targeting drug for…
Stevanato Group Launches US Technology Excellence Center in Boston
Italian-based Stevanato Group, a leading producer of pharmaceutical glass containers and provider of integrated capabilities for drug delivery systems, has officially inaugurated its….
Gerresheimer Enters Development & Production Agreement With Boehringer Ingelheim
Gerresheimer has recently been commissioned by Boehringer Ingelheim with the development and large series production of the housing module for the new generation of….
Orgenesis Announces Agreement to Acquire Koligo Therapeutics
Orgenesis Inc. and Koligo Therapeutics, Inc. recently announced the two companies have entered into a definitive merger agreement, subject to final closing conditions, with expected completion….
Mereo BioPharma Receives FDA Rare Pediatric Disease Designation
Mereo BioPharma Group plc recently announced that the US FDA has granted Rare Pediatric Disease designation to setrusumab for the treatment of osteogenesis imperfecta (OI).…
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
FSD Pharma Inc. recently announced the US FDA has authorized the initiation of a Phase 2 study for the use of FSD201 (ultramicronized palmitoylethanolamide, or…
Celyad Oncology Announces Clinical Trial Collaboration With MSD
Celyad Oncology SA recently announced it has entered into a clinical trial collaboration with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ, through…
